Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Randomized Controlled Study on the Impact of Tongmai Jiangtang Capsules on the Risk of Cardiovascular and Cerebrovascular Events in Metabolic Syndrome

NCT06908473 is registered in ClinicalTrials.gov with Guangdong Provincial Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT06908473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06908473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Randomized Controlled Study on the Impact of Tongmai Jiangtang Capsules on the Risk of Cardiovascular and Cerebrovascular Events in Metabolic Syndrome
Lead sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
April 24, 2025
Completion date
July 31, 2028
Enrollment
530 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease (ckd), cerebrovascular disease, metabolic syndrome, qi deficiency and blood stasis